The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

It's been a good year for the stock market as a whole and a tremendous year for a couple of drugmaker start-ups. Shares of ...

FTC approves Novo Holdings' $16.5B Catalent acquisition. Deal includes selling 3 facilities to Novo Nordisk for $11B, despite ...

New research shows how weight loss meds like Wegovy are reshaping alcohol habits, offering new insights into addiction ...

Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...

In this context, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a potential game-changer. Initially ...

Recent studies show medications like Ozempic, originally designed for type 2 diabetes and weight loss, may help people ...

Lawmakers are considering some small health policy provisions in an end-of-year package – but experts don’t expect anything major.

The biggest factors in the higher cost of American health care are not insurance profits but high prices charged by providers of inpatient and outpatient care and higher administrative costs, ...

The View” co-host Whoopi Goldberg accused Health and Human Services (HHS) nominee Robert F. Kennedy Jr. of fat shaming ...

Brownstein and his team noted that women and adults aged 66 to 75 saw the largest decreases in obesity. People living in the ...

NVO's CagriSema target of up to 25% in long-term weight loss is highly promising vs. 15% through Wegovy and 20% through ...